Henry Schein Inc
NASDAQ:HSIC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
63.92
80.57
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Henry Schein Inc
Henry Schein Inc
Other Equity
Henry Schein Inc
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Henry Schein Inc
NASDAQ:HSIC
|
Other Equity
-$264m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-31%
|
|
|
Cardinal Health Inc
NYSE:CAH
|
Other Equity
-$155m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Adapthealth Corp
NASDAQ:AHCO
|
Other Equity
$1.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Patterson Companies Inc
NASDAQ:PDCO
|
Other Equity
-$85.4m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
|
Mckesson Corp
NYSE:MCK
|
Other Equity
-$890m
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-7%
|
|
|
Cencora Inc
NYSE:COR
|
Other Equity
-$989.1m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
-34%
|
|
Henry Schein Inc
Glance View
In the evolving landscape of healthcare distribution, Henry Schein Inc. has carved out a robust niche, establishing itself as a pivotal player in delivering essential products and services. Founded in 1932, the company initially responded to the growing need for medical supplies with a simple commitment to customer service and innovation. Today, the company profiles as the world’s largest provider of healthcare products and services to office-based dental and medical practitioners, alongside its veterinary arm. It services a global footprint, channeling its efforts into dental, medical, and animal health sectors. The company's sprawling network deploys a vast array of products—from consumables to equipment—to a multitude of healthcare professionals, accentuating its integral role in the clinical toolkit. Henry Schein's revenue engine thrives on a meticulously crafted business model that combines the breadth of a comprehensive catalog with targeted value-added services. Its diverse product offerings span dental implants, vaccines, pharmaceuticals, and surgical supplies, delivered through direct sales and sophisticated logistical frameworks. Moreover, Henry Schein supplements its product lines with a suite of services, including practice management solutions and e-commerce platforms, that streamline operations for practitioners and enhance client loyalty. Strategic partnerships and acquisitions show the company's commitment to innovation, driving efficiencies and expanding its reach. This continuous adaptation keeps Henry Schein at the forefront of healthcare trends, ensuring steady streams of income flowing from both longstanding relationships and new market opportunities.
See Also
What is Henry Schein Inc's Other Equity?
Other Equity
-264m
USD
Based on the financial report for Sep 28, 2024, Henry Schein Inc's Other Equity amounts to -264m USD.
What is Henry Schein Inc's Other Equity growth rate?
Other Equity CAGR 10Y
-31%
Over the last year, the Other Equity growth was -7%. The average annual Other Equity growth rates for Henry Schein Inc have been -24% over the past three years , -6% over the past five years , and -31% over the past ten years .
You don't have any saved screeners yet